================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
August 2, 2005
------------------------------------------------
Date of Report (Date of earliest event reported)
PhotoMedex, Inc.
------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 0-11635 59-2058100
---------------------------- ------------ -------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
147 Keystone Drive, Montgomeryville, Pennsylvania 18936
-------------------------------------------------------
(Address of principal executive offices)
(Zip Code)
(215) 619-3600
--------------------------------------------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 2, 2005, the Registrant reported its results of operations
for the quarter ended June 30, 2005, inclusive of activity from its
acquisition of ProCyte Corporation. A copy of the press release
issued by the Registrant concerning the foregoing results is
attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
The information set forth under "Item 2.02 Results of Operations and
Financial Condition", including the accompanying Exhibit 99.1, is
being furnished in accordance with interim guidance issued by the
Securities and Exchange Commission in Release No. 33-8216. The
information contained herein and in the accompanying exhibit shall
not be incorporated by reference into any filing of the Registrant,
whether made before or after the date hereof, regardless of any
general incorporation language in such filing, unless expressly
incorporated by specific reference to such filing. The information
in this report, including the exhibit hereto, shall not be deemed to
be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended or be otherwise subject to the liabilities of
that section or Sections 11 and 12 (a) (2) of the Securities Act of
1933, as amended.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(C) EXHIBITS.
99.1 Press Release, dated August 2, 2005.
2
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHOTOMEDEX, INC.
Dated: August 2, 2005 By: /s/Jeffrey F. O'Donnell
-----------------------
Jeffrey F. O'Donnell
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit Number Description
- -------------- --------------------------------------------
99.1 Press release, dated August 2, 2005, regarding the
announcement of the Company's earnings for the
quarter ended June 30, 2005, inclusive of activity
from its acquisition of ProCyte Corporation.
4